Apotex - Australian Business' Merger

Apotex - Australian Business raised a round of funding on May 14, 2018. Investors include Arrow Pharmaceuticals.

Apotex is a generic drug producer. Apotex manufactures and distributes generic medications for a range of diseases and health conditions that include cancer, diabetes, high cholesterol, glaucoma, infe…

Articles about Apotex - Australian Business' Merger: